Petro Terblanche

home / authors / petro-terblanche

CEO of Afrigen.

Articles

Timeline for mRNA Vaccine Development for Rift Valley Fever

Sophia Abene;Petro Terblanche;Caryn Fenner

January 23rd 2025

Caryn Fenner and Petro Terblanche outline Afrigen's clinical trial plans, local partnerships, and vaccine pipeline.

Afrigen Biologics Advancing Development of mRNA Vaccine for Rift Valley Fever

Sophia Abene;Caryn Fenner;Petro Terblanche

January 22nd 2025

Caryn Fenner and Petro Terblanche explain how CEPI’s $6.2 million grant will advance Afrigen’s mRNA vaccine for Rift Valley fever through preclinical and Phase I trials in Africa.

Published: August 27th 2024 | Updated: August 28th 2024

Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties

Published: January 17th 2025 | Updated: January 23rd 2025

Seasonal Respiratory Virus Season: How Are We Doing Right Now?

Published: January 21st 2025 | Updated: January 23rd 2025

Rezafungin is Noninferior to Caspofungin For All-Cause Mortality in Treating Candida Infections

Published: January 21st 2025 | Updated: January 23rd 2025

How Prepared Are We For Avian Influenza?

Published: January 17th 2025 | Updated: January 23rd 2025

Advice for Clinicians from Clinicians: Improving Antibiotic Stewardship and Infection Control

Published: March 23rd 2023 | Updated: January 23rd 2025

FDA Approves Antifungal Rezafungin to Treat Candidemia and Invasive Candidiasis

Do Not Sell My Information

Privacy

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

Petro Terblanche

Articles

Latest Updated Articles